Table 2.
Risk of readmission
| Patients with ≥1 readmission, n (%) | Adjusted hazard ratio (95% CI)a | P value | ||
|---|---|---|---|---|
| Neb-LABA | Neb-SABA | |||
| Readmission | 39 (31.7) | 47 (38.2) | 0.53 (0.30–0.96) | 0.0349b |
CI confidence interval, neb-LABA nebulized long-acting β2-agonist, neb-SABA nebulized short-acting β2-agonist
aA hazard ratio <1 indicates that patients in the neb-LABA cohort had a lower risk of experiencing a readmission than patients in the neb-SABA cohort
bSignificant at the 5% level